<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.iongenomics.bio/p/nateras-signatera-wins-first-mrd</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-24T20:04:32+00:00</news:publication_date><news:title>Natera's Signatera Wins First MRD Approval in Japan for Colorectal Cancer</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/illumina-doubles-down-on-newborn</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-23T20:11:48+00:00</news:publication_date><news:title>Illumina Doubles Down on Newborn Sequencing: Ion Genomics Newsletter, June 23, 2026</news:title></news:news></url><url><loc>https://www.iongenomics.bio/p/natera-mrd-test-for-bladder-cancer</loc><news:news><news:publication><news:name>Ion Genomics</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-23T20:10:07+00:00</news:publication_date><news:title>Natera MRD Test for Bladder Cancer Nabs Top-Level US Recommendation</news:title></news:news></url></urlset>